facebook

Is It Time for a Change in Your Hemophilia A Treatment?

With so many choices out there, it's time to narrow the field.

Helixate FS Antihemophilic Factor (Recombinent)

What is important to you in a hemophilia A therapy?

Twice-weekly
dosing option*
ZERO bleeds
(median AsBR)
AFSTYLA Vials

*FDA approved for 2 to 3 times weekly dosing.

What else is important to you?

Once you've found a therapy with a twice-weekly dosing option* and ZERO bleeds (median AsBR), other things can be taken into consideration.

Insurance coverage

Of these 3 FVIII products, only AFSTYLA is covered by 3 of the largest national plans (pharmacy benefit managers).


Heritage you can trust

With more than 30 years of experience in bleeding disorders, CSL Behring remains committed to developing innovative therapies.


ZERO inhibitors observed

ZERO inhibitors were observed in 258 previously treated children, adolescents, and adults in clinical trials.

Ask your doctor if AFSTYLA is right for you

*FDA approved for dosing 2 to 3 times a week.
†AsBR=annualized spontaneous bleeding rate.

Blue Divider

Get the conversation started

Customize a Doctor Discussion Guide and get your questions answered at your next appointment

Purple connector

Getting started with AFSTYLA is simple

When you're ready to give AFSTYLA a try, simply print this form and give it to your doctor to request your free 30-day trial. All insured patients are eligible, including those covered by Medicare and Medicaid.

Be sure to sign up for the latest information on hemophilia A and AFSTYLA—and request your free AFSTYLA Discovery Kit!

If you need assistance, speak with a My Source Care Coordinator at 1-800-676-4266 Monday through Friday, 8 am to 8 pm ET.

You are now leaving the current website.

Do you want to continue?

No Yes